CagriSema vs Tirzepatide | Research Comparison | QSC

CagriSema vs Tirzepatide

Mechanism, Phase 2 data, and research applications compared

Shop Both at QSC →

Factor Cagrilintide Tirzepatide
Receptor AMY1R (amylin-1) GLP-1R+GIPR dual agonist
Best Trial Result −15.6% CagriSema (32wks) −20.9% (72wks)
At QSC ✓ In Stock ✓ In Stock
Research analysis: CagriSema (cagrilintide+sema): AMY1R+GLP-1R combination vs tirzepatide GIPR+GLP-1R — different receptor combination, similar efficacy range.
Research Use Only. All QSC products for in vitro laboratory research only.
Peptides
Orals
Oils
Search
Contact